Table: Jcr Pharmaceuticals - 6-MTH group results

JCR Pharmaceuticals

28/10/2021 08:00

Oct 28 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2021        Sep 30, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               28.38               10.95            52.00    
                  (+159.2 pct)         (-2.5 pct)       (+72.8 pct) 
  Operating           13.64                1.31            21.70    
                  (+943.3 pct)         (+31.0 pct)     (+162.4 pct) 
  Recurring           13.73                1.35            21.70    
                  (+916.4 pct)         (+37.7 pct)     (+155.6 pct) 
  Net                  9.23                1.23            15.40    
                  (+652.6 pct)         (+33.0 pct)     (+123.4 pct) 
  EPS               74.66 yen           9.94 yen        124.70 yen  
  EPS Diluted       74.36 yen           9.89 yen                    
  Ann Div                                                20.00 yen  
  -Q2 div           10.00 yen           18.00 yen                   
  -Q4 div                               7.50 yen         10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T